Silodosin is a selective ?1A-adrenoceptor antagonist used primarily for the symptomatic treatment of benign prostatic hyperplasia (BPH). It works by relaxing smooth muscle in the prostate and bladder neck, thereby improving urine flow and reducing BPH symptoms like hesitancy, weak stream, and nocturia. Its high uroselectivity minimizes effects on b